Literature DB >> 10884880

Microvascular decompression for trigeminal neuralgia: report of outcome in patients over 65 years of age.

B I Ogungbo1, P Kelly, P J Kane, F P Nath.   

Abstract

Microvascular decompression (MVD) is now recognized as an effective operation for the cure of trigeminal neuralgia (TN), and is far superior to the other surgical procedures utilized in the treatment of TN. TN is common in the elderly, but there is debate concerning MVD in 'elderly' patients. Some clinicians have a policy of not offering patients over a certain age the choice of MVD, yet the recurrence rate is inversely related to the age of the patient. Previous failed procedures and a long period of pain before MVD, also affect the outcome negatively. This study is a retrospective review of the outcome in elderly patients following MVD. Forty-two patients over the age of 65 years are reviewed after undergoing MVD for TN. The results indicate that there was no serious morbidity or mortality that could be ascribed to old age and the length of stay in the hospital was not influenced by the age of the patient. The results are compared with the outcome in a younger age group and the literature on MVD for TN reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 10884880     DOI: 10.1080/02688690042861

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  3 in total

1.  Advanced age as a contraindication to microvascular decompression for drug-resistant trigeminal neuralgia: evidence of prejudice?

Authors:  Paolo Ferroli; Francesco Acerbi; Massimo Tomei; Giovanni Tringali; Angelo Franzini; Giovanni Broggi
Journal:  Neurol Sci       Date:  2009-10-06       Impact factor: 3.307

2.  Deep Learning Based Real-Time Semantic Segmentation of Cerebral Vessels and Cranial Nerves in Microvascular Decompression Scenes.

Authors:  Ruifeng Bai; Xinrui Liu; Shan Jiang; Haijiang Sun
Journal:  Cells       Date:  2022-06-02       Impact factor: 7.666

3.  Microvascular decompression for trigeminal neuralgia in the elderly: efficacy and safety.

Authors:  Tobias Greve; Joerg-Christian Tonn; Jan-Hinnerk Mehrkens
Journal:  J Neurol       Date:  2020-08-30       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.